Junxiu Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2012

Location

Yantai Shandong China

Primary Industry

Medical Devices & Equipment

About

Established in 2012 and based in Yantai, China, Junxiu operates as a medical devices developer that focuses on implantable medical devices R&D. The company listed on the new third board in 2016 and the stock code is 839761. In 2017, the company's R&D center was recognized as Yantai medical materials engineering laboratory for human tissue reconstruction. In 2017, Junxiu invested to establish laboratory animal center, including pharmacology, pathology and toxicology testing. Junxiu cooperates with Shandong Academy of Sciences, Shandong Academy of Medical Sciences, Binzhou Medical College, Shenyang Pharmaceutical University. The company provides class III implanted medical devices such as nerve repair catheter, nerve repair membrane and medical chitosan. And it adopts natural biological materials, polymer materials and tissue engineering materials for expression in vitro. Its laboratory's instruments include gas phase, liquid phase, gas quality, liquid quality and atomic absorption. The company's products can apply in orthopedics, neurosurgery, otorhinolaryngology, dermatology and plastic surgery.

Current Investors

Shenzhen Capital Real Estate Fund, Qianhai Ark Asset Management, Qingdao Huatong Venture Capital

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Devices & Equipment

Website

www.ytjunxiu.com

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.